|
Please note that abstracts have not been edited by PAINWeek staff for content, style, or accuracy, and are displayed as input by each submitter.
|
A Comparison of Various Risk Screening Methods for Patients Receiving Opioids for Chronic Pain Management
Ted Jones*, Todd Moore, Susan Daffron, Joe Browder, Jacob Levy, Leslie Allen, Steve Passik |
A Comprehensive Assessment of Pain Clinicians Perceptions and Knowledge of Breakthrough Pain
Bronwyn Boyes, Joan Meyer* |
A Curriculum to Provide Clinical Skills Training to Medical Students on the Interface of Pain and Addiction
T Bradley Tanner*, Mary P Metcalf, Susan E Wilhelm |
A Direct Comparison of Topical Pain Treatments for Acute Musculoskeletal Pain
Joseph V Pergolizzi*, Robert J Raffa, Chris Ghribo, Marco Pappagallo, B Nagar, Charles Fleischer, Stéphane Desjonquères |
A Novel Extended-Release Formulation of Oxycodone/Acetaminophen with Abuse Deterrent Properties
Naama Levy-Cooperman, Edward Sellers, Myroslava Romach, Valerie Gregory, Caroline Fradette* |
A Pain Education School for Veterans with Chronic Non-cancer Pain: Putting Prevention into VA Practice
David Cosio*, Erica Hugo, Shelby Roberts, David Schaefer |
A Prospective Study of Post-operative Pain Management at St James University Hospital, Leeds, United Kingdom.
Abubakr M Hussain*, Helen S Barker, Jill Bem |
A Randomized, Double-Blind Study Evaluating Conversion From Hydrocodone (HCD)/acetaminophen (Vicodin®) to Buprenorphine Transdermal System (BTDS) in Patients With Osteoarthritis Pain
Steven R. Ripa, Bill McCarberg, Catherine L. Munera, Warren Wen*, Craig J. Landau |
A Retrospective Study of Pain Management in Burns Patients admitted to the Emergency Department at Rashid Hospital, Dubai, UAE.
Joanna Ciolpan*, Abubakr M Hussain |
A Science-Based Approach to Responsible Risk Management for a Novel Long-Acting Opioid Analgesic
Kevin M Holman, Sherice Mills, Art Morelli*, Jennie Wang, Marc Deluca, Blaise Hollot, Regina Ruben, Gary Slatko |
A Synergistic Integration of Behavioral and Medical Approaches to Managing Chronic Pain
Synne W Venuti*, Jonas Bromberg, Kevin Zacharoff, Emil Chiauzzi |
A Virtual Reality Environment and Adjuvant for Managing Chronic Pain
Diane J. Gromala*, Steven J. Barnes, Pamela Squire, Meehae Song, Chris Shaw |
An Assessment of Internet-based (Emerging Solutions in Pain) CME Activities for Pain Physicians
Bronwyn N Boyes, Joan Meyer*, Benjamin Whitfield, Gregory Salinas |
An Evaluation of the Long-term Safety and Tolerability of Tapentadol Extended Release (ER): Results of an Open-label Extension Trial
Bettyanne McCann*, Brigitte Kuperwasser, Ilse Van Hove, Thomas Häufel, Robert Lange, Mila Etropolski |
An Online Curriculum on the Interface of Pain and Addiction for Health Care Providers
T Bradley Tanner*, Karen M Rossie, Mary P Metcalf |
An Open-label Pilot Study Evaluating Heated Lidocaine/Tetracaine Patches in the Treatment of Patients with Carpal Tunnel Syndrome
Srinivas Nalamachu*, Julie Jenkins, Michael Smith, James Heusner, Thomas Marriott, Nalamasu Rohit |
An Open-Label, Randomized Comparison of Duloxetine, Pregabalin, and the Combination of Duloxetine and Gabapentin among Patients with Inadequate Pain Response
Robert J Tanenberg, Gordon Irving*, Richard Risser, Jonna Ahl, Sandra K Malcolm |
Assessing Intra-Subject and Inter-Subject Variability in Carisoprodol Metabolism and Excretion in Pain Patients
Stephanie A. Tse*, Brookie M. Best, Amadeo J. Pesce |
ASSESSMENT OF HOSPICE HEALTH PROFESSIONAL’S KNOWLEDGE, VIEWS, AND EXPERIENCE WITH MEDICAL MARIJUANA.
Tanya Telegadis, Mary Lynn McPherson*, Francois Pradel |
Assessment of Psychosocial Distress of Elderly Individuals with COPD and with Chronic Pain, according to the AMA Guides Sixth Edition
Armando S Miciano* |
BEMA® BUPRENORPHINE PRODUCED EFFECTIVE ANALGESIA IN A PHASE 2 PLACEBO-CONTROLLED TRIAL IN SUBJECTS WITH SEVERE PAIN FOLLOWING DENTAL EXTRACTION (POST HOC ANALYSIS)
Stephen Daniels*, Iris Breithaupt, Susan Kerls, David Wright, Andrew Finn |
BEMA® BUPRENORPHINE PRODUCED EFFECTIVE ANALGESIA IN A PHASE 2 PLACEBO-CONTROLLED TRIAL OF MODERATE TO SEVERE PAIN FOLLOWING DENTAL EXTRACTION
Stephen Daniels*, Iris Breithaupt, Susan Kerls, David Wright, Andrew Finn |
Buprenorphine Transdermal System (BTDS) Improves Sleep Disturbances in Patients with Moderate to Severe Chronic Pain
Warren Wen*, Shau Yu Lynch, Catherine L. Munera, Steven R. Ripa |
Clinically Relevant Outcomes in Osteoarthritis: Analysis of Pooled Data From Two Randomized, Placebo-controlled Trials of Duloxetine in Patients With Osteoarthritis of the Knee
Marc C Hochberg, Madelaine Wohlreich, Paula Gaynor, Sylvia Hanna, Tonya Pilkey*, Rick Risser |
Comparable Analgesic Efficacy of Buprenorphine Transdermal System (BTDS) in Patients Over and Under 65 Years of Age
Warren Wen, Shau Yu Lynch*, Catherine L. Munera, Steven R. Ripa |
Comparison of Drug Liking and Positive Subjective Effects of Oral Intact Extended-Release Oxymorphone and Controlled-Release Oxycodone
Edward M. Sellers, Stephen McMorn, Kerri A. Schoedel, Kathleen Zerbe, Bijan Chakraborty, Susan L. Potts, Errol Gould* |
Concomitant Use of Low Dose Aspirin and Non-steroidal Anti-inflammatory Drugs in Elderly Nursing Home Residents
Frank Breve*, Dean Gianarkis |
DART -- Novel Opioid Abuse and Resistance Technology
Gene V. Levinstein*, Michael Libman |
Determining The Pain-Related Impairment Rating Of Individuals With Polytrauma History Over 2 Years And With Chronic Pain, According To The AMA Guides Fifth Edition
Armando S Miciano* |
Development of Naloxone Usage Guidelines Based on Medication Use Evaluation Results
Maria Foy* |
Development of the LAQ: A new questionnaire for detecting deception in the chronic pain population. A validation study comparing two dissimulation groups
Blake H. Tearnan*, Sylvia Ross |
Didactic and experiential curriculum: Recommendations from the Strategic Planning Summit of Pain and Palliative Care Pharmacy
Mary Lynn McPherson*, Christopher Herndon |
Differences among Physician Specialties in the Management of Fibromyalgia Patients: Results from a Cross-Sectional Survey in the United States
Caroline Schaefer, Rebecca Baik, Meghan Hufstader, Michael McNett, Robert Gerwin, Gergana Zlateva, Arthi Chandran* |
Efficacy and Safety of Diclofenac Epolamine Topical Patch, 1.3%, for the Treatment of Acute Back Strain
Joseph S Gimbel, Craig A Paterson, Glenn Pixton, David Jacobs* |
Efficacy of Duloxetine in Patients with Chronic Pain Conditions
Vladimir Skljarevski*, Shuyu Zhang, Smriti Iyengar, Deborah D'Souza, Karla Alaka, Amy Chappell, Sandra Malcolm, Joachim Wernicke |
Evaluation of the Safety and Efficacy of Pregabalin in Older Patients With Neuropathic Pain
David Semel*, T. Kevin Murphy, Gergana Zlateva, Raymond Y. Cheung, Birol Emir |
Exposure to Potential CYP450 Pharmacokinetic Drug-Drug Interactions Among Osteoarthritis Patients: Incremental Risk of Multiple Prescriptions
Joseph V. Pergolizzi*, Sumedha A. Labhsetwar, R. Amy Puenpatom, Seongjung Joo, Rami H. Ben-Joseph, Kent H. Summers |
Fentanyl Absorption from Fentanyl Buccal Soluble Film (FBSF) In The Presence of Mucositis
Larry N. Gever, William Wheeler*, WD Charlie Hill |
Fentanyl Buccal Tablet Compared With Immediate-Release Oxycodone for the Management of Breakthrough Pain in Opioid-Tolerant Patients With Chronic Pain: Efficacy and Safety
Michael A. Ashburn, John Messina*, Fang Xie |
Fentanyl Buccal Tablet Compared with Immediate-Release Oxycodone for the Management of Breakthrough Pain in Opioid-Tolerant Patients With Chronic Pain: Patient Disposition and Dose Titration
Michael A. Ashburn, Kieran A. Slevin, John Messina*, Fang Xie |
Fibromyalgia Burden on Patients and Society: Results from a Cross-Sectional Survey in the United States
Caroline Schaefer, Rebecca Baik, Meghan Hufstader, Michael McNett, Robert Gerwin, Gergana Zlateva, Arthi Chandran* |
Fibromyalgia in Primary Care: Can an Online CME Program Change Clinical Practice?
Sean M. Hayes, Kayla N. Cytryn, Pamela McFadden, Andrew Crim*, Murray Suzanne |
Gabapentin Extended Release (G-ER) For The Once Daily Treatment Of Post Herpetic Neuralgia (PHN)
Christine N Sang, Rekha Sathyanarayana, Frederick J Carter, Eric N Sondag*, Michael Sweeney |
Gaps in the Initial Management of Postherpetic Neuralgia: the BASIK PHN survey
Gregory D. Salinas*, Terry A. Glauser, Mark S. Wallace, Chad Williamson |
Gaps in the Patient Perception of PHN Management
Gregory D. Salinas*, Terry A. Glauser, Mark S. Wallace, Chad Williamson |
Improvements in Pain Associated with Fibromyalgia: Results from 3 Clinical Trials of Milnacipran
Michael Geisser, Robert Palmer, Yong Wang, Wei Chen, R. Michael Gendreau, Jolan Terner-Rosenthal* |
Incidence Rates of Adverse Events (AEs) Affecting the Mouth in Three Clinical Trials of Fentanyl Buccal Soluble Film (FBSF)
Larry N. Gever, William Wheeler* |
Intra-Patient and Inter-Patient Variability in Methadone Metabolism in Pain Patients
Edijs Leimanis*, Brookie M. Best, Amadeo J. Pesce |
Intrasubject and intersubject variability in the metabolic ratio converting hydrocodone to hydromorphone from urine samples in pain patients
Neveen H. Barakat*, Brookie M. Best, Amadeo J. Pesce |
Lack of Association Between Efficacy and Drowsiness in Patients Treated With Cyclobenzaprine Extended-Release
Bill H. McCarberg*, Charles A. Altman, Fang Xie |
Long-term Effectiveness of Chronic Pain Education: A Pilot Study
Charles E. Argoff* |
Long-Term Use of Buprenorphine Transdermal System (BTDS) in Patients with Chronic Pain
Warren Wen*, Catherine L. Munera, Bradley Dain, Steven R. Ripa |
Milnacipran Improves Pain, PGIC, Physical Function, and Depressive Symptoms in Fibromyalgia: Results From a Placebo-Controlled Milnacipran Trial
Lesley Arnold, R. Michael Gendreau, Judy Gendreau, Allan Spera, Yong Wang, Jolan Terner-Rosenthal* |
Observations on the metabolic ratio of oxycodone to oxymorphone in urine samples from pain patients
David A Yee*, Brookie M Best, Amadeo J Pesce |
Observations on the relationship between opiate medications, illicit drugs and heroin use in pain patients
David A. Yee, Brookie M. Best, Amadeo J. Pesce* |
Opioid Use Among Patients with Chronic Nonmalignant Pain Receiving Methylnaltrexone for Opioid-Induced Constipation
Arnold J. Weil, Marc E. Duerden, Seth Schulman, Evan Tzanis, Dahong Yu, Amy Manley, Haying Zhang, Bruce Randazzo, Robert Israel* |
Pain Characteristics of Patients Prescribed Opioid Therapy for Chronic Noncancer Pain: Data From the Opioid Utilization Study
Steven P. Stanos, Charles E. Argoff, Gordon A. Irving, R. Amy Puenpatom, Sanyi Zhao, Errol M. Gould* |
Pain Improvement with Nursing Knowledge: Pain Education Program for Nurses
Maria Foy* |
Pain in The Bleeding Disorders Population- a National Pain Study
Michelle L Witkop*, Angela Lambing, George Divine, Ellen Kachalsky, David Rushlow, Jane Dinnen |
Pain symptoms accompanying chronic post sternotomy pain
Nicoline J van Leersum*, Rutger L van Leersum, Harriette F Verweij, Robert JM Klautz |
painACTION.com: An interactive self-management website for chronic back pain patients
Emil Chiauzzi*, Lynette Pujul, Kevin Zacharoff, Kathleen Bond, Elizabeth Yiu, Mollie Wood |
painACTION.com: An Internet-based Behavioral Intervention to Support Migraine Self-Management and Coping
Jonas Bromberg*, Bond Kathy, Black Ryan, Daniel Surette, Kevin Zacharoff |
Participant Responses to a Web-Based "Ready-for-REMSTM" Educational Initiative
Michael J. Brennan*, Karen Roy, Arvind Narayana |
Patient reported outcomes of pain after dorsal cheilectomy for painful Hallux Rigidus.
Mohammed KH Shah*, Nasser Kurdy |
Patient Self Report vs. Urine Toxicology upon Entry into Chronic Pain Management
Linda Thames*, Linda Dunn, Keith Kirby |
Patients' Perception on Internet-Based Research: Results from a Registry of Patients Taking Prescription Medication Containing Oxycodone Immediate Release for Non-Malignant Pain
Crisanta I. Tapia, Wing Chow*, Kathryn P. Anastassopoulos, Carmela Benson, Meghan Hufstader, Stacey J. Ackerman, Myoung Kim |
Pituitary Tumors and Hypopituitarism in Intractable Pain Patients
Forest S Tennant* |
Post Operative Nausea and Vomiting After a Total Joint Replacement with Spinal Anaesthetic
Sarah J Derman*, Valerie MacDonald, Ramin Mehin |
Predicting Abnormal Urine Drug Testing in Patients on Chronic Opioid Therapy
Kathryn S Bronstein*, Steven D Passik, Laura H Munitz, Harry L Leider |
Preliminary Development of a Semi-Structured Approach to Persistent and Breakthrough Pain Assessment
Michael J. Brennan*, Patricia Bruckenthal, Jeffrey A. Gudin, Douglas C. Schottenstein |
Prevalence of Exposure to Potential CYP450 Pharmacokinetic Drug-Drug Interactions Among Patients with Chronic Low Back Pain Taking Opioids
Joseph V. Pergolizzi*, Sumedha A. Labhsetwar, R. Amy Puenpatom, Seongjung Joo, Rami H. Ben-Joseph, Kent H. Summers |
Primary Care Efficient Practices in the Care of Patients with Fibromyalgia
T. Michelle Brown, Rachel L Police, Arthi B Chandran*, Michael McNett, Stuart L Silverman, Nandini Hadker |
Psychological coping styles that increase risk for opioid misuse
Geralyn Datz*, Regina McConley, Jessica Pierce, Katherine Czar, B. Todd Sitzman |
PTI-609, a novel anti-inflammatory analgesic that binds filamin A
Lindsay Burns*, Hoau-Yan Wang |
Pulsed Radiofrequency Energy For Intractable Pain
Forest S Tennant* |
QTc Interval Screening in Outpatients Receiving Methadone at a Veterans Affairs Medical Center
Stephanie Zi, Tracy Hsu*, Sharya Bourdet |
Quantitative Evaluation of the Functional Status of Individuals with Poly-Trauma history over 2 years and with Persistent Chronic Pain after Spinal Injection Intervention, according to the AMA Guides, Sixth Edition
Armando S Miciano* |
Quantitative Evaluation of the Pain-Related Impairment Rating of Individuals with Mild Traumatic Brain Injury and with Chronic Pain, according to the AMA Guides Fifth Edition
Armando S Miciano* |
Recommendations from the Strategic Planning Summit for Pain and Palliative Care Pharmacists
Chris M Herndon, Mary Lynn McPherson*, Scott Strassels, Lee Kral, Rebecca Finley, David Craig, Suzanne Nesbit |
Remifentanil for analgesia based sedation to provide patient comfort during spinal cord stimulator trials Debbie Davis R.N., William von Kaenel M.D., Joshua Madsen M.D.
Debbie Davis*, William vonKaenel, Joshua Madsen |
Results of an Open-label Dose Conversion and Titration Study of Once-Daily Hydromorphone ER in Opioid-Tolerant Patients With Chronic Low Back Pain
Donald R Taylor*, Srinivas R Nalamachu, Martin E Hale |
Retrospective Assessment of Adverse Events Following Subcutaneous Administration of Methadone in Veterans on a Hospice/Palliative Care Unit
Michael A Gillette*, Scott Donelenko, Kimberleigh Campbell |
Safety and Efficacy of Oxymorphone Extended Release for Patients With Chronic Low Back Pain and Hypertension, Diabetes, or Cardiovascular Disease
John Peniston, Tina Ma, Errol Gould* |
Safety and Tolerability of Once-Daily Hydromorphone ER in Adults With Moderate to Severe Chronic Noncancer and Cancer Pain: Pooled Analysis of 13 Clinical Trials
Martin E Hale*, Mark S Wallace, Donald R Taylor, Michael Kutch, Srinivas R Nalamachu |
Safety and Tolerability of Once-Daily Hydromorphone ER in Opioid-Tolerant Adults With Moderate to Severe Chronic Noncancer and Cancer Pain: Pooled Analysis of 13 Clinical Trials
Srinivas R Nalamachu*, Martin E Hale, Donald R Taylor |
Safety and Tolerability of Sublingual Fentanyl (Abstral®) in Adults With Breakthrough Cancer Pain: Pooled Analysis From 4 Clinical Trials
Srinivas R Nalamachu*, Richard L Rauck, Mark S Wallace, David Hassman, Julian Howell |
Self-Reported Impressions of Diclofenac Potassium Liquid-Filled Soft-Gel Capsules for Acute Pain: Results from a Patient Feedback Program
Donna Kerney*, Eric Kinzler |
Show Me the Money: Cost Savings Associated Addition of a Pharmacist to a Palliative Care Team
Maria Foy* |
Steady State Pharmacokinetics of Once-Daily Hydromorphone ER: A Randomized Study in Healthy Volunteers
Kenneth T Moore*, Dominique St-Fleur, Nadia Cardillo Marricco, Jay Ariyawansa, Véronique Pagé, Jaya Natarajan, Gaetano Morelli, Ute Richarz |
Successful Dose-Finding With Sublingual Fentanyl (Abstral®): Combined Results From 2 Open-Label Titration Studies
Srinivas R Nalamachu*, Richard L Rauck, Mark S Wallace, David Hassman, Julian Howell |
Tapentadol Extended Release (ER) Versus Oxycodone Controlled Release (CR) for Management of Chronic Low Back or Osteoarthritis Pain: Pooled Data Analyses to Evaluate Study Discontinuations Due to Treatment-emergent Adverse Events
David M Biondi*, Xiang Jim, Thomas Häufel, Bruce Moskovitz, Mila Etropolski |
The Effect of Pharmacokinetic Parameters on Euphoria and Drug Liking Following Different Oral Hydromorphone Formulations in Opioid-Experienced, Non-dependent, Recreational Drug Users
Lynn R Webster*, Brad Bath, Robert Medve |
The Efficacy and Safety of Buprenorphine Transdermal System (BTDS) in Opioid-naïve Patients With Moderate to Severe Low Back Pain: A Double-blind Study
Deborah J. Steiner, Steve Sitar, Warren Wen*, Gosford Sawyerr, Catherine L. Munera, Shau Yu Lynch, Steven R. Ripa |
The Efficacy and Safety of Buprenorphine Transdermal System (BTDS) in Patients With Moderate to Severe Low Back Pain: A Double-blind Study
Deborah J. Steiner, Catherine L. Munera, Martin E. Hale, Steven R. Ripa, Craig J. Landau, Warren Wen* |
The Inverse relationship between Job Satisfaction, VAS for Pain, and Workdays Lost Due to Minor Motor Vehicle Accidents
Ranga Krishna, Michael Grinn*, Nicholas Giordano, Ajit Khurpe, Stanley Bleifer |
The National Breakthrough Pain Survey (NBTPS): Design and Methodology
Arvind Narayana*, Nathaniel Katz, Alicia C. Shillington, Russell K. Portenoy |
The Role of a Pain Tracking Tool in Chronic Pain Management: A Survey of Healthcare Providers and Patients
Kevin Zacharoff*, Emil Chiauzzi, Catherine Morlino, Synne Venuti |
The Role of Personal Responsibility in the Occurrence of Prescription Opioid Abuse: An Analysis of the Source of Abused Opioid Prescription Drugs Derived from Public Commentary Submitted to the FDA's Opioid REMS Docket
Kathryn H Keller* |
Topical Diclofenac Solution (Pennsaid®) Compared With Oral Diclofenac in Osteoarthritis of the Knee: Pooled Analysis From 2 Controlled Clinical Trials
Sanford H. Roth*, Fuller Philip |
Treatment Discontinuations From an Open-label Extension Study of Tapentadol Extended Release in Patients With Moderate to Severe Chronic Pain
Robert Lange, Brigitte Kuperwasser, Mila Etropolski, Bernd Lange, Achim Steup, Judy Ashworth, BettyAnne McCann* |
Understanding the Diagnosis and Treatment of Fibromyalgia: A New Approach
Suchita Garg, T Michelle Brown, Arthi B Chandran*, Michael McNett, Stuart L Silverman, Nanadini Hadker |
Use of a Pain Assessment Survey to Address F-Tag 309 Requirements
Frank Breve*, Dean Gianarkis |
Use of Topical Opioids by Intractable Pain Patients
Forest S Tennant* |
Using psychological testing to predict aberrant behavior: Which traits predict elevated risk?
Geralyn Datz*, Blazek Nicole, Pierce Jessica, Czar Katherine |
Variability of morphine metabolism in pain patients
Michelle M. Hughes*, Brookie M. Best, Amadeo J. Pesce |
